Q3 FY2026 · ended Sep 30, 2026 · Revenue $601.77M, -13.7% YoY · Filed Nov 6, 2026
Accendra Health, Inc. (ACH) files with the SEC under industry code 5047, Wholesale-Medical, Dental & Hospital Equipment & Supplies. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $601.8 million and a net loss of $19.7 million. Free cash flow was -$56.6 million. As of Sep 30, 2026 it held $26.6 million in cash and investments and $131.5 million in total debt.
Company profile
- Industry
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (SIC 5047)
- Listed as
- ACH (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- VA
- Headquarters
- Glen Allen, VA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 75252
- Former names
- OWENS & MINOR INC/VA/ (until Dec 31, 2025); O&M HOLDING INC (until Jun 17, 1994); OWENS & MINOR INC (until Mar 9, 1994)
Other Wholesale-Medical, Dental & Hospital Equipment & Supplies companies
- Henry Schein Inc HSIC
- HengHong Technology Inc. HCPC
All 3 Wholesale-Medical, Dental & Hospital Equipment & Supplies companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $601.8M | $613.2M | $627.8M | $709.0M | $697.3M |
| Operating income | $1.3M | -$35.1M | $17.1M | $20.9M | $26.5M |
| Net income | -$19.7M | -$89.1M | -$6.5M | -$56.3M | -$150.3M |
| Diluted EPS | -$0.25 | -$1.16 | -$0.08 | -$0.74 | -$1.94 |
| Operating cash flow | -$17.4M | -$26.0M | -$50.1M | — | — |
| Free cash flow | -$56.6M | -$73.6M | -$91.7M | — | — |
| Total assets | $2.1B | $2.1B | $2.4B | $2.5B | $4.0B |
| Total liabilities | $2.6B | $2.7B | $2.9B | $2.9B | $4.5B |
| Stockholders' equity | -$568.2M | -$550.9M | -$464.8M | -$461.0M | -$429.5M |
| Cash and investments | $26.6M | $7.7M | $336.9M | $282.0M | $32.8M |
| Total debt | $131.5M | $101.6M | $648.7M | $363.6M | $407.4M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 6, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Nov 3, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 2, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Oct 30, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Oct 9, 2026 | Oct 6, 2026 |
All 1002 Accendra Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.